Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05983276
Title Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Loyola University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Loyola University Medical Center RECRUITING Maywood Illinois 60153 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field